Latest Innovation News

Respiri Limited reports a standout December quarter marked by a 67% surge in patient program enrolments and robust revenue growth, bolstered by strategic acquisition synergies from Orb Health. The company is poised for further expansion in 2025 amid promising contract negotiations and evolving US healthcare reimbursement policies.

I Synergy Group Limited has reshaped its board with the resignation of Joshua Hunt, the appointment of Jiayi Yu as Non-Executive Director, and the promotion of Heng Jee Meng to Managing Director, signaling a renewed focus on shareholder value.

Adisyn Ltd has successfully raised $10 million through a heavily oversubscribed placement, signaling strong institutional confidence in its graphene-enhanced semiconductor technology. The capital will accelerate development, commercial partnerships, and operational scaling.

Whitebark Energy moves forward with its bid to acquire King Energy, initiating advanced remote sensing studies to pinpoint hydrogen, helium, and hydrocarbon emissions in South Australia's Officer Basin. These efforts set the stage for targeted geochemical surveys and seismic exploration in 2025.

4DMedical has signed a landmark commercial agreement with Qscan Radiology Clinics, marking its first Australian contract to integrate both Pulmonary Function and Pulmonary Structure imaging products.

Amcor plc and Berry Global Group, Inc. have entered into a definitive all-stock merger agreement, positioning the combined entity as a global leader in consumer and healthcare packaging with expected annual synergies of $650 million.

Amcor plc and Berry Global Group have filed their definitive joint proxy statement with the SEC, marking a key milestone in their planned all-stock merger. Shareholder meetings are scheduled for February 25, 2025, as the companies aim to create a global packaging powerhouse.

Sparc Technologies has committed to Stage 2 of its hydrogen joint venture, secured a pioneering patent in Morocco, and progressed graphene additive trials, signaling momentum in its clean energy and materials innovation.

Paradigm Biopharmaceuticals has secured a $6.3 million R&D Tax Incentive refund, lifting its cash reserves to $31 million and reinforcing its push into Phase 3 osteoarthritis clinical trials.

Top Shelf International Holdings Ltd has agreed to sell its Campbellfield production assets to Idyll Wine Co for $8 million, aiming to streamline operations and reduce debt. The deal paves the way for a new co-packing partnership post-sale.

SomnoMed reports a robust 19.8% revenue increase in Q2 FY25 and updates its full-year guidance, reflecting strong demand and operational improvements amid ongoing production enhancements.

Brazilian Critical Minerals Ltd reports breakthrough test results from its Ema ionic clay rare earth project, producing a high-purity mixed rare earth carbonate and advancing drilling, logistics, and environmental assessments.